The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
Open accessAbstract
Trials of anemia correction in chronic kidney disease have found either no benefit or detrimental outcomes of higher targets. We did a secondary analysis of patients with chronic kidney disease enrolled in the Correction of Hemoglobin in the Outcomes in Renal Insufficiency trial to measure the potential for competing benefit and harm from achieved hemoglobin and epoetin dose trials. In the 4 month analysis, significantly more patients in the high-hemoglobin compared to the low-hemoglobin arm were unable to achieve target hemoglobin and required high-dose epoetin-α. In unadjusted analyses, the inability to achieve a target hemoglobin and high-dose epoetin-α were each significantly associated with increased risk of a primary endpoint (death, myocardial infarction, congestive heart failure or stroke). In adjusted models, high-dose epoetin-α was associated with a significant increased hazard of a primary endpoint but the risk associated with randomization to the high hemoglobin arm did not suggest a possible mediating effect of higher target via dose. Similar results were seen in the 9 month analysis. Our study demonstrates that patients achieving their target had better outcomes than those who did not; and among subjects who achieved their randomized target, no increased risk associated with the higher hemoglobin goal was detected. Prospective studies are needed to confirm this relationship and determine safe dosing algorithms for patients unable to achieve target hemoglobin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
Rao, S. J. (2003) · Journal of the American Statistical Association · doi:10.1198/jasa.2003.s263 · Cited by 1,941
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Analysis of survival by tumor response.
Anderson, J. R., Cain, K. C., & Gelber, R. D. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.11.710 · Cited by 1,107
Analysis of survival by tumor response.
Anderson, J. R., & Davis, R. B. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.1.115 · Cited by 1,000
Eschbach, J. W., Abdulhadi, M. H., Browne, J. K., Delano, B. G., Downing, M. R., Egrie, J. C., Evans, R. W., Friedman, E. A., Graber, S. E., Haley, N. R., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-992 · Cited by 795
Analysing Survival Data From Clinical Trials and Observational Studies
(1996) · Technometrics · doi:10.1080/00401706.1996.10484530 · Cited by 663
Hematocrit Level and Associated Mortality in Hemodialysis Patients
MA, J. Z., EBBEN, J., XIA, H., & COLLINS, A. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103610 · Cited by 577
Erythropoietin receptor mRNA expression in human endothelial cells.
Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E. S., Kessimian, N., & Noguchi, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3974 · Cited by 570
Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548
Hoen, B., Paul-Dauphin, A., Hestin, D., & Kessler, M. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95869 · Cited by 514
Regidor, D. L., Kopple, J. D., Kovesdy, C. P., Kilpatrick, R. D., McAllister, C. J., Aronovitz, J., Greenland, S., & Kalantar-Zadeh, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090997 · Cited by 408
Evans, R. W. (1990) · JAMA · doi:10.1001/jama.263.6.825 · Cited by 406
IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
(2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)70008-x · Cited by 400
Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus
Juul, S. E., Yachnis, A. T., & Christensen, R. D. (1998) · Early Human Development · doi:10.1016/s0378-3782(98)00030-9 · Cited by 289
Epoetin requirements predict mortality in hemodialysis patients
Zhang, Y., Thamer, M., Stefanik, K., Kaufman, J., & Cotter, D. J. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01086-8 · Cited by 271
Hematocrit Levels and Hospitalization Risks in Hemodialysis Patients
XIA, H., EBBEN, J., MA, J. Z., & COLLINS, A. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061309 · Cited by 243
Hoen, B., Kessler, M., Hestin, D., & Mayeux, D. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.3.377 · Cited by 196
Administration of Parenteral Iron and Mortality among Hemodialysis Patients
Feldman, H. I., Joffe, M., Robinson, B., Knauss, J., Cizman, B., Guo, W., Franklin-Becker, E., & Faich, G. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128009.69594.be · Cited by 192
Kovesdy, C. P., Ahmadzadeh, S., Anderson, J. E., & Kalantar-Zadeh, K. (2008) · Kidney International · doi:10.1038/ki.2008.64 · Cited by 169
Iron Administration and Clinical Outcomes in Hemodialysis Patients
Feldman, H. I., Santanna, J., Guo, W., Furst, H., Franklin, E., Joffe, M. M., Marcus, S. M., & Faich, G. A. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133734 · Cited by 143
Erythropoietin Signaling Promotes Invasiveness of Human Head and Neck Squamous Cell Carcinoma
Mohyeldin, A., Lu, H., Dalgard, C. L., Lai, S. Y., Cohen, N. A., Ács, G., & Verma, A. M. (2005) · Neoplasia · doi:10.1593/neo.04685 · Cited by 110
Exercise in Hemodialysis Patients after Treatment with Recombinant Human Erythropoietin
Lundin, P., Akerman, M. J. H., Chesler, R., Delano, B. G., Goldberg, N., Stein, R. A., & Friedman, E. A. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000186443 · Cited by 80
The Normal Hematocrit Study — Follow-up
Besarab, A., Goodkin, D. A., & Nissenson, A. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmc076523 · Cited by 76
Trends in Anemia Management among US Hemodialysis Patients
Coladonato, J. A., Frankenfield, D. L., Reddan, D. N., Klassen, P., Szczech, L. A. M., Johnson, C. A., & Owen, W. F. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013294.11876.80 · Cited by 72
Self-citationRibatti, D., Marzullo, A., Gentile, A., Longo, V., Nico, B., Vacca, A., & Dammacco, F. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02654.x · Cited by 60
Anemia Management in Chronic Kidney Disease: Role of Factors Affecting Epoetin Responsiveness
Eschbach, J. W. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016440.52271.f7 · Cited by 58
Leo, C., Horn, L., Rauscher, C., Hentschel, B., Liebmann, A., Hildebrandt, G., & Höckel, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1285 · Cited by 48
Analysing Survival Data from Clinical Trials and Observational Studies
Roddam, A. (2005) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2005.358_11.x · Cited by 43
Editorials: Recombinant Human Erythropoietin: Has Treatment Reached its Full Potential?
Fishbane, S. N. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00109.x · Cited by 28
Cited by
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Babitt, J. L., & Lin, H. Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111078 · Cited by 1,041
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.04.014 · Cited by 770
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Metadata
- Authors
- Szczech, L. A., Barnhart, H. X., Inrig, J. K., Reddan, D. N., Sapp, S., Califf, R. M., Patel, U. D., & Singh, A. K.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 74
- Issue
- 6
- Pages
- 791-798
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2005973637
- Cited by
- 526
- References
- 34
- FWCI
- 28.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.